T cell receptor alpha variable 19 (TRAV19)

T cell receptor alpha variable 19 (TRAV19) is a protein-coding gene that encodes the variable (V) segment of the alpha chain in the T cell receptor (TCR) complex[1][7]. The TCR is present on the surface of T lymphocytes and is responsible for recognizing processed antigens bound to major histocompatibility complex (MHC) molecules on antigen-presenting cells[2][1][7]. This recognition is a key step in initiating adaptive immune responses. Each TCR is generally a dimer composed of an alpha and a beta chain, both of which have variable and constant regions, allowing for immense diversity in antigen recognition through somatic recombination of V (variable), J (joining), and C (constant) gene segments. TRAV19 specifically refers to one of the many possible V gene segments for the alpha chain[1][3][4]. This segment contributes to the diversity of the T cell repertoire, but by itself is not considered a direct therapeutic target, nor are there drugs that interact directly and specifically with TRAV19. **Note:** TRAV19 is a *gene segment* used in T cell receptor gene recombination and is not itself a surface receptor or direct drug target. There are no known drugs, biomarkers, or direct therapeutic strategies targeting TRAV19 specifically. However, T cell receptors as a whole (particularly via engineered TCRs in immunotherapy) are a major focus of therapeutic research in immunology and oncology[1][2][7].

Other names

TCRAV12S1TCRAV19S1T-cell receptor alpha chain V region HPB-MLTTRAV19TVA19_humanTVA19